Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
5
×
clinical trials
fda
5
×
life sciences
national blog main
5
×
san francisco blog main
biotech
national top stories
new york blog main
san diego blog main
san francisco top stories
boston
deals
indiana blog main
new york top stories
raleigh-durham blog main
san diego top stories
seattle blog main
alnylam pharmaceuticals
boston university
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana top stories
investing
national
raleigh-durham top stories
regeneron pharmaceuticals
rna interference
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
akcea therapeutics
ambys medicines
amicus therapeutics
What
patients
5
×
fda
drug
help
medicine
million
startup
ago
alnylam
analytics
approve
aren’t
awaits
beta
bio
biofourmis
biological
bionics
blood
cancer
closed
crossed
data
decades
decision
developers
developing
device
devices
diabetes
digital
discovered
driven
drugs
eisai
employs
fingers
flags
friday
gene
Language
unset
Current search:
patients
×
" boston top stories "
×
" national blog main "
×
fda
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision